Work

The Ayahuasca’s Psychedelic Component Dmt Potentiates Neuritogenesis in Pc12 Cells

Year: 2023

Type: article

Abstract: Ayahuasca is a psychedelic beverage originally from the Amazon rainforest used in different shamanic settings for a variety of medicinal, spiritual, and cultural purposes. It is prepared by decoction of the vine Banisteriopsis caapi, source of β-carboline alkaloids, and, Psychotria viridis containing the classic psychedelic N,N-dimethyltryptamine (DMT). As part of the “renaissance of psychedelic studies”, several recent reports highlight its potential therapeutic applications for the treatment of depression and substance use disorders, among others.

Source: IBRO Neuroscience Reports

DOI: 10.1016/j.ibneur.2023.08.605

Authors: Mariana Pazos, Ignacio Carrera, Giselle Prunell

Institutions: Instituto de Investigaciones Biológicas Clemente Estable, Universidad de la República de Uruguay

Language: English

Topic: Psychedelics and Drug Studies

Subfield: Clinical Psychology

Field: Psychology

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,500